- Home
- IVVD vs MCFT Comparison
IVVD vs MCFT Comparison
Compare IVVD & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- MCFT
- Stock Information
- Founded
- IVVD 2020
- MCFT 1968
- Country
- IVVD United States
- MCFT United States
- Employees
- IVVD N/A
- MCFT N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- MCFT Marine Transportation
- Sector
- IVVD Health Care
- MCFT Industrials
- Exchange
- IVVD Nasdaq
- MCFT Nasdaq
- Market Cap
- IVVD 351.6M
- MCFT 326.9M
- IPO Year
- IVVD 2021
- MCFT 2015
- Fundamental
- Price
- IVVD $1.61
- MCFT $19.92
- Analyst Decision
- IVVD Strong Buy
- MCFT Hold
- Analyst Count
- IVVD 5
- MCFT 6
- Target Price
- IVVD $6.11
- MCFT $21.50
- AVG Volume (30 Days)
- IVVD 6.2M
- MCFT 107.4K
- Earning Date
- IVVD 11-07-2025
- MCFT 11-06-2025
- Dividend Yield
- IVVD N/A
- MCFT N/A
- EPS Growth
- IVVD N/A
- MCFT N/A
- EPS
- IVVD N/A
- MCFT 0.43
- Revenue
- IVVD $46,210,000.00
- MCFT $284,203,000.00
- Revenue This Year
- IVVD $102.11
- MCFT $9.00
- Revenue Next Year
- IVVD $151.51
- MCFT $9.25
- P/E Ratio
- IVVD N/A
- MCFT $46.52
- Revenue Growth
- IVVD 1941.08
- MCFT N/A
- 52 Week Low
- IVVD $0.35
- MCFT $14.39
- 52 Week High
- IVVD $2.74
- MCFT $23.94
- Technical
- Relative Strength Index (RSI)
- IVVD 46.79
- MCFT 37.72
- Support Level
- IVVD $1.74
- MCFT $20.50
- Resistance Level
- IVVD $2.00
- MCFT $23.08
- Average True Range (ATR)
- IVVD 0.24
- MCFT 0.71
- MACD
- IVVD -0.06
- MCFT -0.15
- Stochastic Oscillator
- IVVD 1.33
- MCFT 9.08
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About MCFT MasterCraft Boat Holdings Inc.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.